Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions.

Griffioen AW, Relou IA, Gallardo Torres HI, Damen CA, Martinotti S, De Graaf JC, Zwaginga JJ, Groenewegen G.

Angiogenesis. 1998;2(3):235-43.

PMID:
14517463
2.

IgA and the IgA Fc receptor.

van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG.

Trends Immunol. 2001 Apr;22(4):205-11. Review.

PMID:
11274926
3.

FcalphaRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity.

van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG.

Nat Med. 2000 Jun;6(6):680-5.

PMID:
10835685
4.

Resolution of cutaneous inflammation after local elimination of macrophages.

Thepen T, van Vuuren AJ, Kiekens RC, Damen CA, Vooijs WC, van De Winkel JG.

Nat Biotechnol. 2000 Jan;18(1):48-51.

PMID:
10625390
5.

In vitro upregulation of carcinoembryonic antigen expression by combinations of cytokines.

Verhaar MJ, Damen CA, Zonnenberg BA, Blijham GH.

Cancer Lett. 1999 May 3;139(1):67-73.

PMID:
10408910
6.

Angiogenesis inhibitors overcome tumor induced endothelial cell anergy.

Griffioen AW, Damen CA, Mayo KH, Barendsz-Janson AF, Martinotti S, Blijham GH, Groenewegen G.

Int J Cancer. 1999 Jan 18;80(2):315-9.

7.

Effect of culture conditions on endothelial cell growth and responsiveness.

Relou IA, Damen CA, van der Schaft DW, Groenewegen G, Griffioen AW.

Tissue Cell. 1998 Oct;30(5):525-30.

PMID:
9839475
8.

Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.

Hellwig SM, Damen CA, van Adrichem NP, Blijham GH, Groenewegen G, Griffioen AW.

Cancer Lett. 1997 Dec 9;120(2):203-11.

PMID:
9461038
9.

CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells.

Griffioen AW, Coenen MJ, Damen CA, Hellwig SM, van Weering DH, Vooys W, Blijham GH, Groenewegen G.

Blood. 1997 Aug 1;90(3):1150-9.

PMID:
9242547
10.

Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium.

Griffioen AW, Damen CA, Blijham GH, Groenewegen G.

Blood. 1996 Jul 15;88(2):667-73.

PMID:
8695814
11.

In vitro effects of methotrexate on human articular cartilage and bone-derived osteoblasts.

van der Veen MJ, Scheven BA, van Roy JL, Damen CA, Lafeber FP, Bijlsma JW.

Br J Rheumatol. 1996 Apr;35(4):342-9.

PMID:
8624637
12.

Endothelial intercellular adhesion molecule-1 expression is suppressed in human malignancies: the role of angiogenic factors.

Griffioen AW, Damen CA, Martinotti S, Blijham GH, Groenewegen G.

Cancer Res. 1996 Mar 1;56(5):1111-17.

13.

Endoglin/CD 105 may not be an optimal tumor endothelial treatment target.

Griffioen AW, Damen CA, Blijham GH, Groenewegen G.

Breast Cancer Res Treat. 1996;39(2):239-42. No abstract available.

PMID:
8872333
14.

Effects of methotrexate on human osteoblasts in vitro: modulation by 1,25-dihydroxyvitamin D3.

Scheven BA, van der Veen MJ, Damen CA, Lafeber FP, Van Rijn HJ, Bijlsma JW, Duursma SA.

J Bone Miner Res. 1995 Jun;10(6):874-80.

PMID:
7572311
16.
17.

Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.

Scheven BA, Damen CA, Hamilton NJ, Verhaar HJ, Duursma SA.

Biochem Biophys Res Commun. 1992 Jul 15;186(1):54-60.

PMID:
1632789

Supplemental Content

Loading ...
Support Center